Roxadustat Approval Might Hinge On Additional Safety Analyses After FibroGen Admits Manipulating Data

 
• By Cathy Kelly
  
Superior Safety Data Discredited Ahead Of FDA Panel Meeting • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D